Earning Preview: Insperity Q1 revenue is expected to increase by 1.47%, and institutional views are cautious

Earnings Agent
Apr 24

Abstract

Insperity plans to report first‑quarter 2026 results on April 30, 2026 Pre-Market, with current projections pointing to revenue of 1.89 billion US dollars and adjusted EPS around 1.23, implying approximately 1.47% year‑over‑year revenue growth and a moderation in profitability versus last year.

Market Forecast

Based on the latest projections for the current quarter, revenue is estimated at 1.89 billion US dollars (+1.47% year over year), adjusted EPS is estimated at 1.23 (−38.97% year over year), and EBIT is estimated at 67.40 million US dollars (−33.44% year over year); margin forecasts are not available. The company’s operating model centers on its core PEO services, where management is targeting steady execution on pricing and retention while balancing benefits‑cost dynamics to stabilize margins. Within that single reportable line of business, the most visible revenue driver this quarter remains the core PEO services base itself, effectively encompassing total revenue at an estimated 1.89 billion US dollars (+1.47% year over year).

Last Quarter Review

In the prior quarter, Insperity delivered revenue of 1.67 billion US dollars (+3.41% year over year), a gross profit margin of 10.31%, a GAAP net loss attributable to shareholders of 33.00 million US dollars (net profit margin −1.98%), and adjusted EPS of −0.60 (year‑over‑year change −1300%). The quarter showed top‑line resilience alongside pressure in profitability as benefit‑cost spread and operating factors weighed on margins. Given the company’s structure as a single reportable business, core services effectively accounted for total revenue of 1.67 billion US dollars, up 3.41% year over year.

Current Quarter Outlook

Main business: Core PEO services

The core services line is expected to carry the quarter, with revenue projected at 1.89 billion US dollars, up 1.47% year over year. The near‑term earnings cadence reflects the company’s own first‑quarter adjusted EPS guidance range of 1.03 to 1.50, with market expectations now centering around 1.23. This alignment suggests the Street anticipates a recovery from the fourth quarter’s loss but still expects profitability to trail last year’s level, consistent with the forecast year‑over‑year decline in EPS and EBIT. The quarter’s operational focus is likely to remain on maintaining client retention, managing worksite employee levels, and executing disciplined pricing so that fees better match the benefit and insurance cost environment. Given the single‑segment model, consistent execution in this core line will be the primary determinant of gross profit and operating leverage in the near term.

The gross margin trajectory is a key watch item after the prior quarter’s 10.31%. While we lack an explicit gross margin forecast, the swing from an EBIT loss in the prior quarter to an expected EBIT of 67.40 million US dollars implies some margin normalization in the first quarter as seasonal and cost factors abate. A meaningful margin rebound would require stable benefits claims costs relative to expectations and continued discipline in pricing. Should benefit cost trends run hotter than expected, it would pressure profitability and could pin adjusted EPS toward the lower half of the company’s guided range.

Cash flow and working capital typically reflect seasonal payroll‑tax and benefits timing in the first quarter, and any variance in claims activity could add noise to quarterly results. The fee revenue yield on worksite employees, client retention trends, and pricing actions collectively determine whether revenue growth converts to earnings growth. With revenue growth projected at a modest 1.47%, the earnings trajectory is set to depend mainly on mix, claims behavior relative to accruals, and SG&A control.

Most promising revenue driver this quarter

Within the company’s single reportable line, the most promising revenue driver remains the core PEO services base, which effectively maps to total revenue and is projected at 1.89 billion US dollars (+1.47% year over year). Execution on client retention and selective new‑business adds can sustain incremental revenue, though the magnitude of net adds is likely to be measured given the modest top‑line growth outlook. Pricing discipline is expected to remain in place, which can support gross profit per worksite employee provided that benefit‑cost trends align with expectations. Against the backdrop of a guided EPS range and a consensus near 1.23, incremental operating efficiency—such as tighter expense control—could provide leverage even if revenue growth remains low.

The path to upside on this revenue driver comes from modest net growth in paid worksite employees combined with fee yield management. The absence of material non‑recurring headwinds in claims or benefits pricing could allow revenue to translate more cleanly into gross profit than in the prior quarter. Conversely, if client churn upticks or pricing encounters resistance, this would cap revenue growth and dampen operating leverage. With a single primary revenue engine, the narrative for the quarter is less about mix and more about the quality of execution on retention, pricing, and cost alignment.

Another constructive factor is the year‑over‑year comparison base. The prior year’s first quarter set a profitability benchmark that the current estimates imply will be challenging; however, the revenue base is still expected to inch up. If management delivers better‑than‑expected control of benefit costs or demonstrates improved fee capture per worksite employee, revenue can marginally exceed the 1.89 billion US dollars estimate and offer mild upside to earnings.

Key stock‑price swing factors this quarter

The first swing factor is the spread between pricing and health‑benefit cost trends. The prior quarter’s 10.31% gross margin and a net profit margin of −1.98% underscored how adverse benefit‑cost variance can compress profitability. Investors will focus on whether claims and accruals normalize in Q1 to support the forecast swing to positive EBIT of 67.40 million US dollars. Any unexpected spike in claims costs would likely weigh on the results relative to the adjusted EPS midpoint of guidance and the 1.23 expectation.

The second swing factor is client retention and worksite employee levels. A small deviation in net worksite employee counts can have an outsized effect on revenue and operating leverage in the quarter, given the modest growth outlook. If retention remains solid and new‑business adds modestly improve, revenue could land slightly above the 1.89 billion US dollars estimate; if retention softens, top‑line growth could undershoot and margins may not expand as anticipated.

The third swing factor is operating expense discipline. With EBIT expected to recover from a prior‑quarter loss to 67.40 million US dollars, the degree of SG&A control and efficiency gains will influence how much of the revenue translates to operating income. Initiatives that streamline operations or reduce discretionary spend can provide earnings support even if revenue growth is modest. Conversely, if costs drift higher due to investments or one‑time items, EBIT could fall below expectations and pull adjusted EPS toward the lower bound of guidance.

Lastly, the guidance update itself can be a catalyst. The company has guided first‑quarter adjusted EPS to 1.03–1.50, and the market’s 1.23 expectation sits within that range. If management updates the outlook for the remainder of 2026—particularly around benefit‑cost expectations and expense plans—it could reshape the earnings trajectory implied by current forecasts. Clear commentary on pricing, retention, and claims experience will therefore be pivotal for the stock’s reaction.

Analyst Opinions

Across the limited set of previews captured in the period from January 1, 2026 to April 23, 2026, bearish views constituted the majority at 100% (1/1), driven by a cautious stance following the fourth‑quarter miss and a first‑quarter adjusted EPS guidance range below earlier external projections. Analysts aggregated by a widely followed data provider had expected a narrower fourth‑quarter adjusted loss than the actual −0.60, and the company’s first‑quarter adjusted EPS guidance of 1.03 to 1.50 trailed a previously cited external projection of about 1.69. This gap between guidance and external projections, combined with the prior quarter’s profitability shortfall, set a cautious tone for near‑term expectations.

The bearish camp emphasizes three points. First, while revenue is projected to grow modestly to 1.89 billion US dollars (+1.47% year over year), the estimated declines in adjusted EPS (−38.97% year over year) and EBIT (−33.44% year over year) indicate that profitability normalization is incomplete. Second, the prior quarter’s gross margin of 10.31% and net margin of −1.98% highlight sensitivity to benefit‑cost trends; without clear evidence of a sustained improvement, some expect near‑term margins to remain constrained. Third, the guidance range suggests management is balancing potential variability in claims and operating costs, which could cap upside to consensus if those factors do not improve.

In evaluating these views, the essential debate is whether benefits claims and pricing alignment can improve quickly enough to lift margins toward historical norms in the near term. If the company’s initiatives on pricing discipline and expense control take hold, the projected EBIT swing to 67.40 million US dollars in the first quarter could be a step toward stabilization, even if year‑over‑year comparisons remain negative. Conversely, if the margin headwinds seen in the prior quarter persist into the first quarter, adjusted EPS could skew toward the lower end of guidance.

Cautious commentators also note that the stock’s reaction to the fourth‑quarter results—where shares declined on the report day—signals a market that wants firmer evidence of margin recovery before rewarding the name with higher valuation multiples. Retaining the quarterly dividend of 0.60 suggests confidence in long‑term cash generation, but near‑term earnings uncertainty keeps a lid on sentiment. As a result, the current majority view remains guarded into the print, expecting revenue near 1.89 billion US dollars but looking for proof points on margin normalization and cost control before turning more constructive.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10